Evidence map›Paper›PMID 24204016›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2014

FutureTox: building the road for 21st century toxicology and risk assessment practices.

J Craig Rowlands, Miriam Sander, James S Bus, FutureTox Organizing Committee

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. FutureTox IV Workshop Summary: Predictive Toxicology for Healthy Children.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Programming microphysiological systems for children's health protection.Experimental biology and medicine (Maywood, N.J.) · 2017
    Article
  8. FutureTox III: Bridges for Translation.Toxicological sciences : an official journal of the Society of Toxicology · 2017
    Article
  9. Article
  10. Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.Journal of the American Association for Laboratory Animal Science : JAALAS · 2015
    Article
  12. FutureTox II: in vitro data and in silico models for predictive toxicology.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Article
  13. Proteomics for systems toxicology.Computational and structural biotechnology journal · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J Craig Rowlands* The Dow Chemical Company, Midland, Michigan 48674.
Miriam Sander
James S Bus
FutureTox Organizing Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article reports on the outcome of FutureTox, a Society of Toxicology (SOT) Contemporary Concepts in Toxicology (CCT) workshop, whose goal was to address the challenges and opportunities associated with implementing 21st century technologies for toxicity testing, hazard identification, and risk assessment. One goal of the workshop was to facilitate an interactive multisector and discipline dialog. To this end, workshop invitees and participants included stakeholders from governmental and regulatory agencies, research institutes, academia, and the chemical and pharmaceutical industry in Europe and the United States. The workshop agenda was constructed to collectively review and discuss the state-of-the-science in these fields, better define the problems and challenges, outline their collective goals for the future, and identify areas of common agreement key to advancing these technologies into practice.

Indexed as

Congresses as TopicEuropeGovernment RegulationRisk AssessmentToxicologyUnited Statesin vitro and alternativesregulatory/policy.risk assessment

Identifiers

PMID24204016
PMCPMC3908722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.